Atb Cap Markets upgraded shares of Trulieve Cannabis (TSE:TRU – Free Report) from a hold rating to a strong-buy rating in a research note published on Monday,Zacks.com reports. Atb Cap Markets also issued estimates for Trulieve Cannabis’ FY2025 earnings at ($0.81) EPS.
Trulieve Cannabis Stock Performance
Trulieve Cannabis Company Profile
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Further Reading
- Five stocks we like better than Trulieve Cannabis
- High Flyers: 3 Natural Gas Stocks for March 2022
- The Great CPU Race: AMD and Intel Battle for Dominance
- What is a Secondary Public Offering? What Investors Need to Know
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- How to Use the MarketBeat Stock Screener
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
